T. Rowe Price Associates’s Biohaven BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.7M | Buy |
3,171,235
+348,261
| +12% | +$4.91M | 0.01% | 759 |
|
|
2025
Q1 | $67.9M | Sell |
2,822,974
-589,217
| -17% | -$14.2M | 0.01% | 629 |
|
|
2024
Q4 | $127M | Sell |
3,412,191
-26,335
| -0.8% | -$984K | 0.01% | 522 |
|
|
2024
Q3 | $172M | Buy |
3,438,526
+154,047
| +5% | +$7.7M | 0.02% | 460 |
|
|
2024
Q2 | $114M | Sell |
3,284,479
-62,543
| -2% | -$2.17M | 0.01% | 522 |
|
|
2024
Q1 | $183M | Buy |
3,347,022
+212,699
| +7% | +$11.6M | 0.02% | 435 |
|
|
2023
Q4 | $134M | Buy |
3,134,323
+791,181
| +34% | +$33.9M | 0.02% | 492 |
|
|
2023
Q3 | $60.9M | Buy |
2,343,142
+165,926
| +8% | +$4.32M | 0.01% | 622 |
|
|
2023
Q2 | $52.1M | Buy |
2,177,216
+532,275
| +32% | +$12.7M | 0.01% | 692 |
|
|
2023
Q1 | $22.5M | Buy |
1,644,941
+328,737
| +25% | +$4.49M | ﹤0.01% | 893 |
|
|
2022
Q4 | $18.3M | Buy |
+1,316,204
| New | +$18.3M | ﹤0.01% | 934 |
|